Several studies have shown that SMARCA4 can maintain the growth of myeloid and lymphoid leukemia cells, primarily because SMARCA4 mediates the expression of MYC and PU.1 (85, 105–108). Here, SMARCA4 is linked to lymphoid leukemia.